CREB1 and renal carcinoma: On one hand, factors such as ACh can activate the cAMP/PKA/CREB pathway, leading to the upregulation of MMP2/9) and EMT‐related molecules, thereby promoting the proliferation, invasion, and metastasis of renal cancer cells.